The Claim
Dexamethasone increases the expression of genes involved in triacylglycerol synthesis and lipid storage, including GPC4, AGPAT9, and ACSL1, preferentially in omental adipose tissue relative to abdominal subcutaneous adipose tissue in obese women.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese women, the drug dexamethasone increases the activity of specific genes that promote fat storage in visceral fat tissue around the organs more than in under-the-skin fat tissue.
See the scientific wording
Dexamethasone increases expression of genes involved in triacylglycerol synthesis and lipid storage (e.g., GPC4, AGPAT9, ACSL1) preferentially in omental adipose tissue compared to abdominal subcutaneous tissue in obese women, suggesting a molecular mechanism for glucocorticoid-driven visceral fat accumulation.
When the stress hormone dexamethasone enters fat cells, it turns on genes that build and store fat more strongly in the deep belly fat around organs than in the fat under the skin. This happens because the deep belly fat cells have a unique molecular setup that makes them more responsive to the hormone, causing more fat to be made and stored there while the skin fat cells respond differently and store less.
What the research says
1 studyIn obese women, dexamethasone (a stress hormone mimic) turned on fat-storing genes more in belly fat around organs than in the fat just under the skin — which helps explain why stress leads to more dangerous belly fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.